Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acne
TAZORAC compliance program launched for teens
August 26th, 2005
PediaMed announced the launch of the TAZORAC (tazarotene) Mobile Compliance Program - 8TDAZE, designed to motivate teens through their mobile phone to use their acne medication as directed for best results. The 8TDAZE program created for TAZORAC, a topical retinoid indicated for the treatment of acne vulgaris, encourages teens to apply the medicine regularly through text messages received from the mobile "Buddy" they have selected and offers a selection of wallpapers and ringtones throughout the treatment period. "TAZORAC is an effective medication that has been proven to have a fast response rate with most patients noticing a difference in as little...
Source: Drug Week (2005-08-26)
|
